Get the Stockscreener App
0.6375
6.96%
0.0415
After Hours:
.63
-0.0075
-1.18%
Equillium Inc stock is traded at $0.6375, with a volume of 5.89M.
It is up +6.96% in the last 24 hours and up +98.60% over the past month.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$0.596
Open:
$0.57
24h Volume:
5.89M
Relative Volume:
1.91
Market Cap:
$22.77M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-4.5471
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
+65.76%
1M Performance:
+98.60%
6M Performance:
-32.50%
1Y Performance:
-12.66%
1-Day Range:
$0.55
$0.7961
1-Week Range:
$0.3702
$1.36
52-Week Range:
$0.27
$1.50
Equillium Inc Stock (EQ) Company Profile
Name
Equillium Inc
Sector
Industry
Phone
(858) 412-5302
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
0.6375 | 21.29M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.65 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.13 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.14 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.15 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
298.52 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-29-21 | Resumed | Stifel | Buy |
| Sep-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-14-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Resumed | Stifel | Buy |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
View All
Equillium Inc Stock (EQ) Latest News
Combining price and volume data for Equillium Inc.Weekly Trend Watch with Market Signals - Newser
Published on: 2025-08-06 05:14:45 - Newser
Equillium Shares Drop 12.4% After Unveiling Cryptocurrency Treasury Strategy - MSN
Ranking Equillium Inc. among high performing stocks via toolsLow Volatility Stock Analysis With Confidence - Newser
Historical volatility pattern of Equillium Inc. visualizedBollinger Band Squeeze and Expansion Analysis - Newser
What makes Equillium Inc. stock attractive to long term investorsDaily Stock Watch Summary with Key Insights - Newser
Equillium Inc Reports Q2 2025 EPS of -0.19, Expands Cryptocurrency Strategy to Enhance Liquidity and Long-term Capital Appreciation - AInvest
Will Equillium Inc. stock go up soonLow Drawdown Stock Screener with Analysis - Newser
Equillium Embraces Digital Currencies in Treasury Strategy to Enhance Growth and Diversification - AInvest
Equillium Announces Strategic Expansion To Integrate Cryptocurrency Treasury Reserve Strategy As Part Of Its Broader Financial And Growth Objectives - 富途牛牛
Equillium stock falls after announcing cryptocurrency treasury strategy By Investing.com - Investing.com Australia
Equillium stock falls after announcing cryptocurrency treasury strategy - Investing.com
Equillium adds cryptocurrency to treasury strategy amid cash concerns - Investing.com
Biotech Pioneer Equillium Makes Bold Move Into Crypto While Advancing Novel Drug Development - Stock Titan
Spotlight On 3 Promising Penny Stocks With Over $20M Market Cap - simplywall.st
Tools to monitor Equillium Inc. recovery probability3-Day Market Movement Forecast Analysis - Newser
What is the dividend policy of Equillium Inc. stockAchieve rapid portfolio growth with expert help - Jammu Links News
What makes Equillium Inc. stock price move sharplyExtraordinary profit generation - Jammu Links News
How volatile is Equillium Inc. stock compared to the marketBuild a winning investment strategy today - Jammu Links News
Is Equillium Inc. stock overvalued or undervaluedCapitalize on market trends with confidence - Jammu Links News
Why is Equillium Inc. stock attracting strong analyst attentionSignificant capital appreciation - Jammu Links News
Is Equillium Inc. stock a good hedge against inflationSmart Entry Watchlist with Daily Analysis - Newser
Does Equillium Inc. stock perform well during market downturnsAchieve rapid financial growth with expert picks - Jammu Links News
Is Equillium Inc. a growth stock or a value stockMaximize portfolio growth with strategic plans - Jammu Links News
Equillium Inc. Stock Analysis and ForecastInvest confidently with proven investment plans - Jammu Links News
What is the risk reward ratio of investing in Equillium Inc. stockGet exclusive market analysis for investors - Jammu Links News
How does Equillium Inc. compare to its industry peersTriple-digit return opportunities - Jammu Links News
When is Equillium Inc. stock expected to show significant growthExplosive capital gains - Jammu Links News
What institutional investors are buying Equillium Inc. stockAchieve breakthrough growth with proven strategies - Jammu Links News
What analysts say about Equillium Inc. stockAccelerated investment success - Jammu Links News
Should I hold or sell Equillium Inc. stock in 2025Maximize gains with expert trading strategies - Jammu Links News
Why Equillium Inc. stock attracts strong analyst attentionPattern Recognition Tool for ROI Investors - Newser
Multi factor analysis applied to Equillium Inc.Strong Buy Opportunity with Volume Support - Newser
Published on: 2025-08-02 05:02:00 - Newser
How high can Equillium Inc. stock goFree Low Risk Equity Screener With Results - Newser
How to track smart money flows in Equillium Inc.Free Oversold Bounce Stock Play Ideas - Newser
How does Equillium Inc. generate profit in a changing economyWealth Building Picks That Work - Jammu Links News
Should you hold or exit Equillium Inc. nowFree Capital Efficiency Optimized Stock Alerts - Newser
Equillium Inc Stock (EQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):